CN219398616U - Portable depression therapeutic instrument based on photobiological regulation effect - Google Patents

Abstract

The utility model relates to the technical field of medical instruments, and particularly discloses a portable depression therapeutic apparatus based on a photobiological regulation function, which comprises a head-wearing shell and a nose-wearing body, wherein the inner surface of the head-wearing shell is provided with a first irradiation module which is arranged in an array, the nose-wearing body is provided with a second irradiation module which can irradiate into nostrils of a human body, and the portable depression therapeutic apparatus also comprises a power module which supplies power for the first irradiation module and the second irradiation module.

Description

Portable depression therapeutic instrument based on photobiological regulation effect

Technical Field

The utility model relates to the technical field of medical appliances, in particular to a portable depression therapeutic apparatus based on a photobiological regulation effect.

Background

Depression is a globally high-frequency mental disorder, one of the most common mental disorders. Current methods of treating depression are mainly drug therapy, psychotherapy and physical therapy, which require further research and improvement. Currently, innovative therapies for a variety of neurological and psychological disorders, brain-light bioregulation (PBM) therapies using red to Near Infrared (NIR) have emerged, with PBM therapies primarily used to enhance neuronal metabolic capacity, anti-inflammatory, anti-apoptotic and antioxidant responses, promote neurogenesis and synapse formation, and can improve depression. However, because of the exponential decay of light in tissue in transcranial PBM methods, it is difficult to provide sufficient doses to achieve optimal stimulation. Therefore, the portable transcranial-nasal cavity PBM device is designed to be used for treating depression patients, can overcome the attenuation problem, achieves a better treatment effect, and reduces treatment cost and pressure on medical resources.

Disclosure of Invention

Aiming at the defects in the prior art, the utility model aims to provide a portable depression therapeutic apparatus based on the photobiological regulation function, which has the advantages of convenient use, portability, no wound and the like and has higher therapeutic effect.

The utility model provides a portable depression therapeutic apparatus based on photobiological regulation, which comprises a head-wearing shell and a nose-wearing body, wherein the inner surface of the head-wearing shell is provided with first irradiation modules which are arranged in an array manner, the nose-wearing body is provided with second irradiation modules which can irradiate into nostrils of a human body, and the first irradiation modules and the second irradiation modules are used for irradiating near infrared rays into the cranium of the human body; the device comprises a first irradiation module, a second irradiation module, a power module for supplying power to the first irradiation module and the second irradiation module, and a controller connected with the first irradiation module and the second irradiation module in a signal mode, wherein the controller is used for controlling the light wavelength, the irradiation time and the irradiation power of the first irradiation module and the second irradiation module.

The head wearing shell and the nose wearing body in the therapeutic apparatus provided by the technical scheme can be worn at the head and the nose respectively, and the first irradiation modules arranged in an array are arranged in the head wearing shell and can emit near infrared rays, irradiate the skull through the near infrared rays and penetrate the skull to enter the brain. Simultaneously, near infrared rays generated by the second irradiation module are used for irradiating subcortical and cortical structures of the limbic systems related to Alzheimer's disease and Parkinson's disease in the brain from nostrils, and the omnibearing irradiation is used for enhancing the metabolic capacity of neurons, improving the metabolic activity and blood flow of the brain, stimulating neurogenesis and synapse formation, affecting neurotransmitters and providing neuroprotection through anti-inflammatory and antioxidant signal paths, so that depression symptoms are improved. The device adopts the power module to supply power more portable, can control various parameters through the controller when in use, and is favorable for improving the treatment effect.

Further, an installation box is arranged on the outer side of the head-wearing shell, and the controller and the power module are arranged in the installation box.

Further, the two sides of the head-wearing shell body are provided with first abdication openings corresponding to the ears of the human body.

Further, the front side of the head-wearing shell is provided with a second abdication opening corresponding to the face of the human body.

Further, the lower end of the front side of the head-wearing shell is provided with a restraint part for fixing the head-wearing shell.

Further, a pair of insertion parts capable of being inserted into nostrils of a human body are arranged on the inner side of the nose wearing body, and the insertion parts are flexible.

Further, the front end of the insertion part is provided with a detachable flexible sleeve.

Further, the wavelength of near infrared rays emitted by the first irradiation module and the second irradiation module is 600-1100nm.

The beneficial effects of the utility model are as follows: the head wearing shell and the nose wearing body in the therapeutic apparatus can be worn at the head and the nose respectively, the near infrared rays irradiate the skull and penetrate the skull to enter the brain, the omnibearing irradiation can enhance the metabolic capacity of neurons, improve the metabolic activity and blood flow of the brain, stimulate the neurogenesis and synapse formation, influence neurotransmitters, and provide neuroprotection through anti-inflammatory and antioxidant signal paths, thereby improving depression symptoms. The device has high portability, convenient use and higher practical value and popularization value.

Drawings

In order to more clearly illustrate the embodiments of the present utility model or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below. Like elements or portions are generally identified by like reference numerals throughout the several figures. In the drawings, elements or portions thereof are not necessarily drawn to scale.

Fig. 1 is a diagram showing a structure of a head-wearing case of a portable depression therapeutic apparatus based on a photobiological adjustment according to an embodiment of the present utility model.

Fig. 2 is a diagram showing a nose wearing body structure of a portable depression therapeutic apparatus based on photobiological adjustment according to an embodiment of the present utility model.

Fig. 3 is a schematic diagram showing the therapeutic effect of the portable therapeutic apparatus for depression based on photobiological adjustment according to the embodiment of the present utility model.

Reference numerals: the nose cup assembly comprises a head housing 100, a first relief port 110, a second relief port 120, a restraint 130, a nose cup assembly 200, a first illumination module 300, a mounting box 400, an insertion portion 500, and a flexible sleeve 600.

Detailed Description

Embodiments of the technical scheme of the present utility model will be described in detail below with reference to the accompanying drawings. The following examples are only for more clearly illustrating the technical aspects of the present utility model, and thus are merely examples, and are not intended to limit the scope of the present utility model.

It should be noted that terms or words used in the present specification and claims should not be construed in a general or dictionary sense unless otherwise stated, but should be construed only in a sense and a concept conforming to the technical idea of the present utility model on the basis of the principle that "the inventor properly defines the concept of terms in order to explain his own utility model in an optimal manner".

As shown in fig. 1 and 2, the embodiment of the present utility model provides a portable depression therapeutic apparatus based on a photobiological adjustment, which includes a head-wearing case 100 and a nose-wearing body 200, and the head-wearing case 100 and the nose-wearing body 200 can be worn at head and nose positions, respectively. In order to realize the photo-biological adjustment treatment, the inner surface of the head wearing shell 100 is provided with a first irradiation module 300 which is arranged in an array, the nose wearing body 200 is provided with a second irradiation module which can irradiate into the nostrils of the human body, and the first irradiation module 300 and the second irradiation module are used for irradiating near infrared rays into the cranium of the human body; the device further comprises a power supply module for supplying power to the first irradiation module 300 and the second irradiation module, wherein the first irradiation module 300 and the second irradiation module are further connected with a controller in a signal mode, and the controller is used for controlling the light wavelength, the irradiation time and the irradiation power of the first irradiation module 300 and the second irradiation module.

Through the arrangement, the therapeutic apparatus mainly uses red to near-infrared (NIR) light biological regulation according to the infrared light treatment principle in the prior art; red/near infrared light stimulates the IV enzyme of the mitochondrial respiratory chain (cytochrome C oxidase) and increases ATP synthesis, with long-term impact on cells. While studies have demonstrated that PBM can reduce ROS in oxidatively stressed cells, inhibition of inflammatory responses in activated inflammatory cells by inhibition of reduced pro-inflammatory cytokines of the NF-. Kappa.B signaling pathway, tumor necrosis factor-alpha (tumor necrosis factor-a, TNF-. Alpha.) and Interleukins (IL) such as IL-1β, IL-6, IL-10 and IL-18 are among the most studied examples associated with PBM treatment. It has been shown that PBM irradiation of the brain can improve brain metabolic activity and blood flow, stimulate neurogenesis and synapse formation, affect neurotransmitters, and provide neuroprotection through anti-inflammatory and antioxidant signaling pathways, improving depressive symptoms.

As shown in fig. 1 and 2, the first irradiation module 300 disposed in an array arrangement within the head-wearing case 100 is capable of emitting near infrared rays, irradiating the skull through the near infrared rays and penetrating the skull to enter the interior of the brain. The first irradiation module 300 may use a transcranial multidirectional irradiation method of a multi-LED array, and not only may enhance uniformity of brain photon flux and photon distribution, but also may avoid an internal temperature increase. Similarly, near infrared light generated by the second illumination module is illuminated from the nostrils to subcortical (hypothalamus, thalamus, amygdala, hippocampus) and cortical (prefraorbital cortex) structures of the limbic system associated with alzheimer's disease and parkinson's disease in the brain; the omnibearing irradiation can strengthen the metabolism of neurons, improve the metabolic activity and blood flow of brain, stimulate neurogenesis and synapse formation, affect neurotransmitters, provide neuroprotection through anti-inflammatory and antioxidant signal channels, solve the problem of insufficient penetration of light in craniocerebral tissues, and the like, thereby obviously improving depression symptoms. The device adopts the power module to supply power more portable, can control various parameters through the controller when in use, and is favorable for improving the treatment effect. In practical application, the wavelength of near infrared rays emitted by the first irradiation module and the second irradiation module is 600-1100nm.

As shown in fig. 1 and 2, in order to improve portability of the present therapeutic apparatus, the present embodiment is provided with a mounting box 400 outside the head-wearing case 100, and the controller and the power module are built in the mounting box 400. The mounting box 400 can accommodate the controller structure and the power module, thereby improving the compactness of the device, and the power module adopts a rechargeable battery and is provided with a charging interface on the mounting box 400, so that the use of a user is facilitated. The controller may be connected to control buttons provided on the outside of the mounting box 400 to facilitate control of parameters.

As shown in fig. 1 and 2, in order to facilitate the wearing of the head-wearing case 100 by a user, the present embodiment is provided with first abdication openings 110 corresponding to the ears of the human body on both sides of the head-wearing case 100. The front side of the head-wearing shell 100 is provided with a second abdication opening 120 corresponding to the face of the human body. Further, a restraint 130 for fixing the head-wearing case 100 is provided at the front lower end of the head-wearing case 100. Thus, the first yielding port 110 and the second yielding port 120 can avoid interference of the head-wearing shell 100 when the head-wearing shell is worn, and the head-wearing shell has higher wearing comfort, the shell can be restrained by the restraining portion 130, the wearing stability is improved, and the restraining portion 130 can adopt a buckle and other structures.

As shown in fig. 1 and 2, the nose wearing body 200 of the present embodiment needs to be worn at a nose position, and the present embodiment is provided with a pair of insertion portions 500 capable of being inserted into nostrils of a human body inside the nose wearing body 200, and the insertion portions 500 have flexibility. In this way, the insertion portion 500 is designed in an elongated cylindrical shape, which can minimize the loss of the breathing ability of the user; in addition, the front end of the insertion part 500 is provided with a detachable flexible sleeve 600, and the comfort level can be improved by adopting the flexible sleeve 600, and the flexible sleeve has the characteristics of light weight, small volume and the like, so that a wearer can breathe freely without feeling uncomfortable, and the flexible sleeve is preferably made of a silica gel material in practical application.

PBM therapy techniques can improve brain metabolic activity and blood flow, stimulate neurogenesis and synapse formation, affect neurotransmitters, and provide neuroprotection through anti-inflammatory and antioxidant signaling pathways. So far, serious adverse reactions in this way have not been reported in the literature. As shown in fig. 3, the applicant picked in the actual test a chart of the score of the hamilton depression scale for 10 patients with depression at the initial, 2-week and 4-week PBM treatment. High scores mean more depression, 15 scores or more suggesting clinical depression. No adverse events or side effects were found immediately after the first visit to the laboratory and after detailed interrogation of the patient 2 and 4 weeks after treatment.

Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present utility model, and not for limiting the same; although the utility model has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some or all of the technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit of the utility model, and are intended to be included within the scope of the appended claims and description.

Claims (6)

1. The portable depression therapeutic apparatus based on the photobiological regulation is characterized by comprising a head-wearing shell (100) and a nose-wearing body (200), wherein a first irradiation module (300) which is arranged in an array is arranged on the inner surface of the head-wearing shell (100), a second irradiation module which can irradiate into the nostrils of a human body is arranged on the nose-wearing body (200), and the first irradiation module (300) and the second irradiation module are used for irradiating near infrared rays into the cranium of the human body; the device further comprises a power supply module for supplying power to the first irradiation module (300) and the second irradiation module, wherein the first irradiation module (300) and the second irradiation module are also connected with a controller in a signal manner, and the controller is used for controlling the light wavelength, irradiation time and irradiation power of the first irradiation module (300) and the second irradiation module;

a pair of insertion parts (500) capable of being inserted into nostrils of a human body are arranged on the inner side of the nose wearing body (200), and the insertion parts (500) are flexible; the front end of the insertion part (500) is provided with a detachable flexible sleeve (600).

2. The portable depression therapeutic apparatus based on photobiological regulation as claimed in claim 1, wherein a mounting box (400) is provided on the outside of the head-mounted housing (100), and the controller and the power module are built in the mounting box (400).

3. The portable depression therapeutic apparatus based on photobiological regulation according to claim 1, wherein the two sides of the head-wearing shell (100) are provided with first abdication openings (110) corresponding to the ears of the human body.

4. The portable depression therapeutic apparatus based on photobiological regulation according to claim 1, wherein the front side of the head-wearing case (100) is provided with a second relief port (120) corresponding to the face of the human body.

5. The portable depression therapeutic apparatus based on photobiological regulation according to claim 1, wherein a restraint part (130) for fixing the head-wearing case (100) is provided at a lower end of a front side of the head-wearing case (100).

6. The portable depression therapeutic apparatus based on photobiological regulation as claimed in claim 1, wherein the first and second irradiation modules emit near infrared light having a wavelength of 600-1100nm.